sterol/neoplasms

INTRODUCTION The present invention relates to sterols, their fatty acid esters and glucosides; to processes for their preparation; to spontaneously dispersible agents containing these compounds, and to their use for treatment of tumours. Surprisingly, it has been found that mainly the sterols

BACKGROUND OF THE INVENTION 1. Field of Invention The present invention relates to methods and compositions for oral delivery of nutrients and/or pharmaceuticals, particularly for tissue repair and regeneration of the body, and more particularly to methods and compositions for protecting the mucosal

FIELD OF THE INVENTION The present invention relates to methods for storing tumor cells, such as tissue samples, biopsies or explants. More specifically, the invention is directed to simple and effective methods of storing tumor cells, wherein the RNA and/or DNA in the cells is essentially not

FIELD OF THE INVENTION The present invention relates to pharmaceutical compounds in the field of chemical and biological sciences, particularly to anti-tumor drugs CL168 with general structural formula I and II, and their synthesis method and use. BACKGROUND OF THE INVENTION Tumor is one of the main

CROSS REFERENCE TO RELATED APPLICATION The present application is the U.S. national stage of International Application PCT/SE2014/050380, filed Mar. 31, 2014, which international application was published on Oct. 9, 2014, as International Publication No, WO2014/163558. The International Application

FIELD OF INVENTION The present invention regards nanoparticles comprising sterol and a component derived from Quillaja saponaria Molina selected from quillaja acid and quillaja saponin, which nanoparticles do not comprise a phospholipid as an essential component. It also relates to a composition

FIELD OF INVENTION The present invention regards nanoparticles comprising sterol and a component derived from Quillaja saponaria Molina selected from quillaja acid and quillaja saponin, which nanoparticles do not comprise a phospholipid as an essential component. It also relates to a composition

FIELD OF INVENTION The present invention regards nanoparticles comprising sterol and a component derived from Quillaja saponaria Molina selected from quillaja acid and quillaja saponin, which nanoparticles do not comprise a phospholipid as an essential component. It also relates to a composition

TECHNICAL FIELD The present disclosure relates to the field of pharmacy, and in particular to a sterol derivative with Structural Formula (I), a preparation method and a use thereof. BACKGROUND Monascus-fermented rice is a reddish purple rice starter prepared from rice fermented by Monascus.

FIELD OF INVENTION This invention relates to novel compounds for use as steroid sulphatase inhibitors, and pharmaceutical compositions containing them. BACKGROUND AND PRIOR ART Steroid precursors, or pro-hormones, having a sulphate group in the 3-position of the steroid nucleus) referred to

This application is a 371 of PCT/GB92/01587. FIELD OF INVENTION This invention relates to novel compounds for use a steroid sulphatase inhibitors, and pharmaceutical compositions containing them. BACKGROUND AND PRIOR ART Steroid precursors, or pro-hormones, having a sulphate group in the 3-position

FIELD OF INVENTION This invention relates to novel compounds for use as steroid sulphatase inhibitors, and pharmaceutical compositions containing them. BACKGROUND AND PRIOR ART Steroid precursors, or pro-hormones, having a sulphate group in the 3-position of the steroid nucleus, referred to

This application is a 371 of PCT/6B92/01586 filed Aug. 28, 1992. FIELD OF INVENTION This invention relates to novel compounds for use as steroid sulphatase inhibitors, and pharmaceutical compositions containing them. BACKGROUND AND PRIOR ART Steroid precursors, or pro-hormones, having a sulphate

Etherlipids are synthetic analogues of platelet activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine), an effector generally believed to be involved in a variety of physiological processes, such as inflammation, the immune response, allergic reactions and reproduction. Etherlipids

Etherlipids are synthetic analogues of platelet activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine), an effector generally believed to be involved in a variety of physiological processes, such as inflammation, the immune response, allergic reactions and reproduction. Etherlipids